Alzinova AB (OSTO:ALZ) Other Financing : kr-1.48 Mil (TTM As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Alzinova AB Other Financing?

Alzinova AB's Other Financing for the three months ended in Dec. 2023 was kr0.00 Mil.

Alzinova AB's Other Financing for the trailing twelve months (TTM) ended in Dec. 2023 was kr-1.48 Mil.

Alzinova AB Other Financing Historical Data

The historical data trend for Alzinova AB's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alzinova AB Other Financing Chart

Alzinova AB Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Financing

Get a 7-Day Free Trial

-9.95

-6.71

-1.48

Alzinova AB Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Other Financing	Get a 7-Day Free Trial															-	-	-1.48	-	-

Alzinova AB Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-1.48 Mil.

Alzinova AB Other Financing Related Terms

Thank you for viewing the detailed overview of Alzinova AB's Other Financing provided by GuruFocus.com. Please click on the following links to see related term pages.

Alzinova AB (OSTO:ALZ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alzinova AB (OSTO:ALZ) » Definitions » Other Financing

Comparable Companies

Traded in Other Exchanges

78D:Germany

Address

Pepparedsleden 1, Molndal, SWE, SE-431 83

Website

https://www.alzinova.com

Alzinova AB is a Swedish biotechnology company engaged in the discovery and development of therapeutics for the treatment of Alzheimer's disease. The company is also engaged in development of a specific oligomer-directed vaccine (ALZ-101), as well as on the development of diagnostics based on a monoclonal antibody. The product is in clinical development as a therapeutic vaccine for the treatment of Alzheimer's.

Alzinova AB (OSTO:ALZ) Headlines

No Headlines